Latest Commercialization News

Telix Pharmaceuticals has exceeded its full-year 2024 revenue guidance, driven by strong sales of its prostate cancer diagnostic Illuccix® and strategic pipeline advancements.

Foresta Group Holdings secures a significant regulatory boost as its Kawerau renewable energy project is included in New Zealand’s Fast-Track Approvals Act 2024, expediting the path to construction and operation.

TMK Energy has successfully initiated gas flows from three new pilot wells at its Gurvantes XXXV Project, doubling total field production and advancing toward critical desorption pressures expected by mid-2025.

Syrah Resources has been awarded a US$165 million tax credit under the US Inflation Reduction Act to support the expansion of its Vidalia active anode material facility in Louisiana, potentially increasing production capacity to 45ktpa.

Unith Ltd has strengthened its financial position through a partial divestment in AudioStack while renewing a key public health contract and achieving its highest B2C subscription revenue in two years.

Pointerra has won a US$2 million contract extension from the US Department of Energy to expand its hurricane impact analysis program, leveraging its Pointerra3D digital twin technology to enhance electric grid resilience across North America.

Renergen has confirmed ongoing LNG production and helium liquefaction at its Phase 1 plant, addressing recent share price volatility and outlining plans to boost capacity through additional wells.

FBR Limited has received a substantial A$6.3 million R&D tax incentive rebate from the Australian Taxation Office, strengthening its financial position as it wraps up its US Demonstration Program with additional funding from CRH Ventures.

Livium and Mineral Resources have agreed to extend their joint development agreement, funding additional optimisation activities for the LieNA® lithium extraction technology and setting the stage for a 50/50 joint venture.

Invictus Energy has successfully renewed its SG 4571 licence in Zimbabwe’s Cabora Bassa Basin for an additional three years, enabling continued exploration and development at the Mukuyu gas discovery.

4DMedical has landed a paid pilot contract with the US Department of Defense to deploy its CT:VQ™ lung imaging technology on active-duty personnel, marking a significant step before FDA submission and spotlighting a billion-dollar market opportunity.

Pacific Edge faces a significant Medicare reimbursement setback as Novitas finalizes a non-coverage decision for its Cxbladder tests, prompting the company to activate legal challenges and operational restructuring.